Test Price
2,800 AED✅ Home Collection Available
MPL Gene Congenital Amegakaryocytic Thrombocytopenia (CAMT) NGS Test in Dubai, UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Executive Summary
This advanced genetic diagnostic test provides comprehensive analysis of the MPL gene using ISO-accredited Next-Generation Sequencing (NGS) technology, delivering 99.9% diagnostic sensitivity. Logistics include VIP mobile phlebotomy with temperature-controlled cold-chain home collection (available daily 8 AM – 11 PM) and post-test telephonic result interpretation by a clinical geneticist. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015‑accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy with cold‑chain home collection (8 AM – 11 PM).
- Clinical Guidance: Post‑test telephonic result interpretation by a Consultant Medical Genetics.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MPL gene NGS test is designed to detect pathogenic variants associated with congenital amegakaryocytic thrombocytopenia (CAMT), a rare inherited bone marrow failure syndrome. The methodology combines full gene coverage (>500x depth) with orthogonal Sanger confirmation to ensure variant accuracy. This test guides definitive diagnosis and informs critical treatment decisions, including hematopoietic stem cell transplantation.
| Parameter | Our CAMT NGS Test | Standard Single‑Gene Sanger |
|---|---|---|
| Precision | Full gene coverage, variant depth >500x | Selected exon hotspots only |
| Methodology | NGS + orthogonal Sanger confirmation | Sanger sequencing |
| Speed | 3–4 Weeks (comprehensive analysis) | 6–8 Weeks (outsourced) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)
"Genetic testing for MPL mutations provides a definitive diagnosis for CAMT, but results must be interpreted alongside clinical findings, platelet counts, and bone marrow evaluation. A negative result does not rule out other congenital thrombocytopenias. Parents should receive comprehensive pre-test counselling regarding recurrence risks and the implications for family planning."
Medication Advisory
DO NOT discontinue any prescribed medication without consulting your physician. This genetic test is a diagnostic tool and does not replace urgent clinical assessment or emergency care. Continue all treatments as directed until further medical advice.
Patient Safety & Exclusion Criteria
- Not for use in acute haemorrhage or emergency room triage.
- Unsuitable if no personal or family history of thrombocytopenia or parental carrier screening indication.
- Minors require mandatory parental consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Red‑Flag Symptoms – Seek Immediate Emergency Care
- Sudden, uncontrolled bleeding or hematoma formation.
- Widespread petechiae, purpura, or spontaneous bruising.
- Signs of intracranial haemorrhage (severe headache, altered consciousness).
Patient FAQ & Clinical Guidance
1. What is the MPL gene CAMT test?
This test identifies mutations in the MPL gene that cause congenital amegakaryocytic thrombocytopenia (CAMT), a rare inherited bone marrow failure disorder. It is performed on a peripheral blood sample using Next-Generation Sequencing to detect full-gene variants.
2. How is the sample collected and processed?
A peripheral blood sample is collected via VIP mobile phlebotomy at your home. The sample is transported under controlled cold-chain conditions to our ISO-accredited laboratory. DNA is extracted and the MPL gene is sequenced using NGS with orthogonal Sanger confirmation.
3. What is the turnaround time and cost?
Results are provided within 3-4 weeks from sample receipt. The total cost is 2,800 AED, with direct insurance billing support available. Please contact our billing team for pre-authorization details.
UAE Regulatory & Data Privacy Adherence
This test and its associated data handling comply with the following UAE federal laws:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – protecting patient genetic data privacy.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing digital health records and telephonic consultations.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring informed consent and clinical safety standards for genetic testing.
All genetic results are reported in accordance with the DHA’s standards for diagnostic genomics.
Clinical & Logistical Metadata
| Test Name | MPL Gene Congenital Amegakaryocytic Thrombocytopenia (CAMT) NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (DNA Extraction) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) with Orthogonal Sanger Confirmation |
| ICD-10-CM Code | D69.4 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians